Traws Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Traws Pharma, Inc. (TRAW) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents21.3420.8238.7655.0719.0322.7316.97
Cash & Short-Term Investments21.3420.8238.7655.0719.0322.7316.97
Accounts Receivable1.770.020.030.030.040.100.04
Inventory0.000.190.100.030.090.000.00
Other Current Assets0.180.170.040.040.210.140.07
Total Current Assets24.9522.6639.3555.4319.7823.4717.77
Non-Current Assets
Property, Plant & Equipment (Net)0.010.020.020.040.050.050.01
Other Non-Current Assets0.000.000.000.010.150.150.15
Total Non-Current Assets0.010.020.030.050.200.200.16
Total Assets24.9622.6839.3755.4819.9923.6717.92
Current Liabilities
Accounts Payable8.195.623.862.769.808.076.55
Accrued Liabilities2.863.382.771.924.960.000.00
Deferred Revenue0.230.230.230.230.230.000.00
Other Current Liabilities3.120.001.191.222.240.000.01
Total Current Liabilities11.539.228.056.1210.028.298.44
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.000.00
Other Non-Current Liabilities42.490.000.000.000.320.000.00
Total Non-Current Liabilities45.062.793.023.243.473.704.10
Total Liabilities56.5912.0111.069.3613.8111.9912.54
Stockholders' Equity
Common Stock0.040.010.210.210.120.000.00
Retained Earnings-649.15-482.63-463.68-444.72-428.54-403.40-381.90
Accumulated Other Comprehensive Income-0.04-0.02-0.03-0.010.01-0.02-0.01
Additional Paid-in Capital617.53493.32491.82490.64434.59413.88387.24
Shares Outstanding3.650.840.840.840.000.000.00
Total Stockholders' Equity-31.6310.6728.3146.126.1811.695.39
Total Liabilities & Equity24.9622.6839.3755.4819.9923.6717.92